Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, HIV Infections, Date of authorisation: 16/12/2016, Revision: 11, Status: Authorised | Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, HIV Infections, Date of authorisation: 16/12/2016, Revision: 11, Status: Authorised | | Human medicines European public assessment report (EPAR): Cervarix, human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), Papillomavirus Infections;Uterine Cervical Dysplasia;Immunization, Date of authorisation: 20/09/2007, Rev | Human medicines European public assessment report (EPAR): Cervarix, human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), Papillomavirus Infections;Uterine Cervical Dysplasia;Immunization, Date of authorisation: 20/09/2007, Revision: 38, Status: Authorised | | |